Journal article 369 views 32 downloads
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants
ALTEX, Volume: 41, Issue: 1
Swansea University Author: Martin Clift
-
PDF | Version of Record
© The Authors, 2023. This work is licensed under a Creative Commons Attribution 4.0 International License.
Download (879.74KB)
DOI (Published version): 10.14573/altex.2305311
Abstract
In vitro methods provide a key opportunity to model human-relevant exposure scenarios for hazardidentification of inhaled toxicants. Compared to in vivo tests, in vitro methods have the advantageof assessing effects of inhaled toxicants caused by differences in dosimetry, e.g., variations in concent...
Published in: | ALTEX |
---|---|
ISSN: | 1868-596X |
Published: |
ALTEX Edition
2024
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa65429 |
first_indexed |
2024-01-09T19:02:41Z |
---|---|
last_indexed |
2024-11-25T14:16:03Z |
id |
cronfa65429 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2024-03-21T12:04:36.4860478</datestamp><bib-version>v2</bib-version><id>65429</id><entry>2024-01-09</entry><title>The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants</title><swanseaauthors><author><sid>71bf49b157691e541950f5c3f49c9169</sid><ORCID>0000-0001-6133-3368</ORCID><firstname>Martin</firstname><surname>Clift</surname><name>Martin Clift</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-01-09</date><deptcode>MEDS</deptcode><abstract>In vitro methods provide a key opportunity to model human-relevant exposure scenarios for hazardidentification of inhaled toxicants. Compared to in vivo tests, in vitro methods have the advantageof assessing effects of inhaled toxicants caused by differences in dosimetry, e.g., variations in concentration(exposure intensity), exposure duration, and exposure frequency, in an easier way.Variations in dosimetry can be used to obtain information on adverse effects in human-relevantexposure scenarios that can be used for risk assessment. Based on the published literature ofexposure approaches using air-liquid interface models of the respiratory tract, supplemented withadditional experimental data from the EU H2020 project “PATROLS” and research funded by theDutch Ministry of Agriculture, Nature and Food Quality, the advantages and disadvantages of differentexposure methods and considerations to design an experimental setup are summarized anddiscussed. As the cell models used are models for the respiratory epithelium, our focus is on thelocal effects in the airways. In conclusion, in order to generate data from in vitro methods for riskassessment of inhaled toxicants it is recommended that (1) it is considered what information really isneeded for hazard or risk assessment; (2) the exposure system that is most suitable for the chemicalto be assessed is chosen; (3) a deposited dose that mimics deposition in the human respiratory tractis used, and (4) the post-exposure sampling methodology should be carefully considered and relevantto the testing strategy used.</abstract><type>Journal Article</type><journal>ALTEX</journal><volume>41</volume><journalNumber>1</journalNumber><paginationStart/><paginationEnd/><publisher>ALTEX Edition</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1868-596X</issnPrint><issnElectronic/><keywords>In Vitro; Toxicology; Inhalation; Lung; Risk Assessment</keywords><publishedDay>9</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-01-09</publishedDate><doi>10.14573/altex.2305311</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders>This re-search was funded by the Dutch Ministry of Agriculture, Nature and Food Quality, project 10B.5.1-4. This research is part of the NWA-ORC VHP4Safety research project. The VHP4Safety re-search project is funded by the Netherlands Research Council (NWO) “Netherlands Research Agenda: Research on Routes by Consortia” (NWA-ORC 1292.19.272). B. Rothen-Rutishauser acknowledges the NRP 79 grant (Nr. 407940_206331/1) from the Swiss National Science Foundation and the Adolphe Merkle Foun-dation. The research reported in supplementary file 2 was sup-ported by EU-project PATROLS (Physiologically Anchored Tools for Realistic nanomaterial hazard aSsessment), No. 760813, and by the Dutch Ministry of Infrastructure and Water Management.</funders><projectreference/><lastEdited>2024-03-21T12:04:36.4860478</lastEdited><Created>2024-01-09T18:55:29.4549888</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Martin</firstname><surname>Clift</surname><orcid>0000-0001-6133-3368</orcid><order>1</order></author></authors><documents><document><filename>65429__29424__a81ff0f6462c4cfd988fde71d306c22a.pdf</filename><originalFilename>Staal et al (2024).pdf</originalFilename><uploaded>2024-01-09T19:02:00.4563313</uploaded><type>Output</type><contentLength>900854</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© The Authors, 2023. This work is licensed under a Creative Commons Attribution 4.0 International License.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2024-03-21T12:04:36.4860478 v2 65429 2024-01-09 The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants 71bf49b157691e541950f5c3f49c9169 0000-0001-6133-3368 Martin Clift Martin Clift true false 2024-01-09 MEDS In vitro methods provide a key opportunity to model human-relevant exposure scenarios for hazardidentification of inhaled toxicants. Compared to in vivo tests, in vitro methods have the advantageof assessing effects of inhaled toxicants caused by differences in dosimetry, e.g., variations in concentration(exposure intensity), exposure duration, and exposure frequency, in an easier way.Variations in dosimetry can be used to obtain information on adverse effects in human-relevantexposure scenarios that can be used for risk assessment. Based on the published literature ofexposure approaches using air-liquid interface models of the respiratory tract, supplemented withadditional experimental data from the EU H2020 project “PATROLS” and research funded by theDutch Ministry of Agriculture, Nature and Food Quality, the advantages and disadvantages of differentexposure methods and considerations to design an experimental setup are summarized anddiscussed. As the cell models used are models for the respiratory epithelium, our focus is on thelocal effects in the airways. In conclusion, in order to generate data from in vitro methods for riskassessment of inhaled toxicants it is recommended that (1) it is considered what information really isneeded for hazard or risk assessment; (2) the exposure system that is most suitable for the chemicalto be assessed is chosen; (3) a deposited dose that mimics deposition in the human respiratory tractis used, and (4) the post-exposure sampling methodology should be carefully considered and relevantto the testing strategy used. Journal Article ALTEX 41 1 ALTEX Edition 1868-596X In Vitro; Toxicology; Inhalation; Lung; Risk Assessment 9 1 2024 2024-01-09 10.14573/altex.2305311 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Another institution paid the OA fee This re-search was funded by the Dutch Ministry of Agriculture, Nature and Food Quality, project 10B.5.1-4. This research is part of the NWA-ORC VHP4Safety research project. The VHP4Safety re-search project is funded by the Netherlands Research Council (NWO) “Netherlands Research Agenda: Research on Routes by Consortia” (NWA-ORC 1292.19.272). B. Rothen-Rutishauser acknowledges the NRP 79 grant (Nr. 407940_206331/1) from the Swiss National Science Foundation and the Adolphe Merkle Foun-dation. The research reported in supplementary file 2 was sup-ported by EU-project PATROLS (Physiologically Anchored Tools for Realistic nanomaterial hazard aSsessment), No. 760813, and by the Dutch Ministry of Infrastructure and Water Management. 2024-03-21T12:04:36.4860478 2024-01-09T18:55:29.4549888 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Martin Clift 0000-0001-6133-3368 1 65429__29424__a81ff0f6462c4cfd988fde71d306c22a.pdf Staal et al (2024).pdf 2024-01-09T19:02:00.4563313 Output 900854 application/pdf Version of Record true © The Authors, 2023. This work is licensed under a Creative Commons Attribution 4.0 International License. true eng https://creativecommons.org/licenses/by/4.0/ |
title |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants |
spellingShingle |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants Martin Clift |
title_short |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants |
title_full |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants |
title_fullStr |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants |
title_full_unstemmed |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants |
title_sort |
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants |
author_id_str_mv |
71bf49b157691e541950f5c3f49c9169 |
author_id_fullname_str_mv |
71bf49b157691e541950f5c3f49c9169_***_Martin Clift |
author |
Martin Clift |
author2 |
Martin Clift |
format |
Journal article |
container_title |
ALTEX |
container_volume |
41 |
container_issue |
1 |
publishDate |
2024 |
institution |
Swansea University |
issn |
1868-596X |
doi_str_mv |
10.14573/altex.2305311 |
publisher |
ALTEX Edition |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science |
document_store_str |
1 |
active_str |
0 |
description |
In vitro methods provide a key opportunity to model human-relevant exposure scenarios for hazardidentification of inhaled toxicants. Compared to in vivo tests, in vitro methods have the advantageof assessing effects of inhaled toxicants caused by differences in dosimetry, e.g., variations in concentration(exposure intensity), exposure duration, and exposure frequency, in an easier way.Variations in dosimetry can be used to obtain information on adverse effects in human-relevantexposure scenarios that can be used for risk assessment. Based on the published literature ofexposure approaches using air-liquid interface models of the respiratory tract, supplemented withadditional experimental data from the EU H2020 project “PATROLS” and research funded by theDutch Ministry of Agriculture, Nature and Food Quality, the advantages and disadvantages of differentexposure methods and considerations to design an experimental setup are summarized anddiscussed. As the cell models used are models for the respiratory epithelium, our focus is on thelocal effects in the airways. In conclusion, in order to generate data from in vitro methods for riskassessment of inhaled toxicants it is recommended that (1) it is considered what information really isneeded for hazard or risk assessment; (2) the exposure system that is most suitable for the chemicalto be assessed is chosen; (3) a deposited dose that mimics deposition in the human respiratory tractis used, and (4) the post-exposure sampling methodology should be carefully considered and relevantto the testing strategy used. |
published_date |
2024-01-09T08:21:45Z |
_version_ |
1821302383304507392 |
score |
11.263136 |